Skip to main content
Have a personal or library account? Click to login
Herd-Trained Immunity: A Hidden Component of Population-Level Innate Immunity Cover

Herd-Trained Immunity: A Hidden Component of Population-Level Innate Immunity

Open Access
|Jun 2026

References

  1. Abo YN, Oliver J, McMinn A et al. (2023) Increase in invasive group A Streptococcal disease among Australian children coinciding with northern hemisphere surges. Lancet Reg Health West Pac 41:100873. https://doi.org/10.1016/j.lanwpc.2023.100873
  2. Ammar S, Anglemyer A, Bennett J et al. (2024) Post-pandemic increase in invasive group A Strep infections in New Zealand. J Infect Pub Health 17:102545. https://doi.org/10.1016/j.jiph.2024.102545
  3. Baker RE, Park SW, Yang W et al. (2020) The impact of COVID-19 nonpharmaceutical interventions on the future dynamics of endemic infections. Proc Natl Acad Sci USA 117:30547–30553. https://doi.org/10.1073/pnas.2013182117
  4. Boraschi D, Italiani P (2018) Innate immune memory: Time for adopting a correct terminology. Front Immunol 9:799. https://doi.org/10.3389/fimmu.2018.00799
  5. Brueggemann AB, Jansen van Rensburg MJ, Shaw D et al. (2021) Changes in the incidence of invasive disease due to Streptococcus pneumoniae, Haemophilus influenzae, and Neisseria meningitidis during the COVID-19 pandemic in 26 countries and territories in the invasive respiratory infection surveillance initiative: A prospective analysis of surveillance data. Lancet Digit Health 3:e360–e370. https://doi.org/10.1016/S2589-7500(21)00077-7
  6. Brueggeman JM, Zhao J, Schank M et al. (2022) Trained immunity: An overview and the impact on COVID-19. Front Immunol 13:837524. https://doi.org/10.3389/fimmu.2022.837524
  7. Cai J, Zhou X, Zhang C et al. (2025) Ongoing epidemic of scarlet fever in Shanghai and the emergence of M1UK lineage group A Streptococcus: A 14-year surveillance study across the COVID-19 pandemic period. Lancet Region Health West Pac 58:101576. https://doi.org/10.1016/j.lanwpc.2025.101576
  8. Chen J, Gao L, Wu X et al. (2023) BCG-induced trained immunity: History, mechanisms and potential applications. J Transl Med 21:106. https://doi.org/10.1186/s12967-023-03944-8
  9. Commons RJ, Smeesters PR, Proft T et al. (2014) Streptococcal superantigens: Categorization and clinical associations. Trends Mol Med 20:48–62. https://doi.org/10.1016/j.molmed.2013.10.004
  10. Cunningham M (2000) Pathogenesis of Group A Streptococcal infections. Clin Microbiol Rev 13:470–511. https://doi.org/10.1128/cmr.13.3.470
  11. den Hartog G, van Kasteren PB, Schepp RM et al. (2023) Decline of RSV-specific antibodies during the COVID-19 pandemic. Lancet Infect Dis 23:23–25. https://doi.org/10.1016/s1473-3099(22)00763-0
  12. Dinleyici EC, Borrow R, Safadi MAP et al. (2021) Vaccines and routine immunization strategies during the COVID-19 pandemic. Hum Vaccin Immunother 17:400–407. https://doi.org/10.1080/21645515.2020.1804776
  13. Emami S, Westerlund E, Converso TR et al. (2023) Protection conferred by intraperitoneal group A Streptococcus immunization relies on macrophages and IFN-γ but not on concurrent adaptive immune responses. bioRxiv:2023.2010.2031.564887. https://doi.org/10.1101/2023.10.31.564887
  14. Fieber C, Kovarik P (2014) Responses of innate immune cells to group A Streptococcus. Front Cell Infect Microbiol 4:140. https://doi.org/10.3389/fcimb.2014.00140
  15. Goldberg-Bockhorn E, Hagemann B, Furitsch M et al. (2024) Invasive group A Streptococcal infections in Europe after the COVID-19 pandemic. Dtsch Arztebl Int 121:673–680. https://doi.org/10.3238/arztebl.m2024.0127
  16. Górka J, Skupnik W, Mikiewicz M et al. (2023) Rapidly progressive Streptococcal toxic shock syndrome epidemic in Kraków, 2023. Pol Arch Intern Med 133:16570. https://doi.org/10.20452/pamw.16570
  17. Götzinger F, Santiago-García B, Noguera-Julián A et al. (2020) COVID-19 in children and adolescents in Europe: A multinational, multicentre cohort study. Lancet Child Adolesc Health 4:653–661. https://doi.org/10.1016/S2352-4642(20)30177-2
  18. Infectious diseases and poisonings in Poland (annual reports 2019–2023). (2026) https://wwwold.pzh.gov.pl/oldpage/epimeld/index_p.html. Accessed 30 March 2026
  19. Lappin E, Ferguson AJ (2009) Gram-positive toxic shock syndromes. Lancet Infect Dis 9:281–290. https://doi.org/10.1016/S1473-3099(09)70066-0
  20. Lorenz N, James A, Van Rooyen T et al. (2025) Decline of antibodies to major viral and bacterial respiratory pathogens during the COVID-19 pandemic. J Infect Dis 231:e77–e81. https://doi.org/10.1093/infdis/jiae611
  21. Lynskey NN, Jauneikaite E, Li HK et al. (2019) Emergence of dominant toxigenic M1T1 Streptococcus pyogenes clone during increased scarlet fever activity in England: A population-based molecular epidemiological study. Lancet Infect Dis 19:1209–1218. https://doi.org/10.1016/S1473-3099(19)30446-3
  22. Marcinkiewicz J (2024) Increase in the incidence of invasive bacterial infections following the COVID-19 pandemic: Potential links with decreased herd trained immunity – a novel concept in medicine. Pol Arch Intern Med 134:16794. https://doi.org/10.20452/pamw.16794
  23. Marcinkiewicz J (2025) Post-pandemic upsurge of group A Streptococcus infections: Potential link to impaired herd trained immunity following COVID-19 lockdowns. Front Immunol 16:1684332. https://doi.org/10.3389/fimmu.2025.1684332
  24. Matsumura T, Takahashi Y (2020) The role of myeloid cells in prevention and control of group A Streptococcal infections. Biosafety Health 2:130–134. https://doi.org/10.1016/j.bsheal.2020.05.006
  25. Munro AP, House T (2024) Cycles of susceptibility: Immunity debt explains altered infectious disease dynamics post-pandemic. Clin Infect Dis 81:1173–1176. https://doi.org/10.1093/cid/ciae493
  26. Musumeci S, MacPhail A, Weisser Rohacek M et al. (2025) Role of viral coinfection in post-pandemic invasive Group A streptococcal infections in adults, a nation-wide cohort study (iGAS-WISS). Eur J Clin Microbiol Infect Dis 44:2677–2684. https://doi.org/10.1007/s10096-025-05229-y
  27. Needle RF, Russell RS (2023) Immunity debt, a gap in learning, or immune dysfunction? Viral Immunol 36:1–2. https://doi.org/10.1089/vim.2022.0204
  28. Netea MG, Domínguez-Andrés J, Barreiro LB et al. (2020) Defining trained immunity and its role in health and disease. Nat Rev Immunol 20:375–388. https://doi.org/10.1038/s41577-020-0285-6
  29. Netea MG, Quintin J, van der Meer JWM (2011) Trained immunity: A memory for innate host defense. Cell Host Microbe 9:355–361. https://doi.org/10.1016/j.chom.2011.04.006
  30. Netea MG, Ziogas A, Benn CS et al. (2023) The role of trained immunity in COVID-19: Lessons for the next pandemic. Cell Host Microbe 31:890–901. https://doi.org/10.1016/j.chom.2023.05.004
  31. Nygaard U, Hartling UB, Munkstrup C et al. (2024a) Invasive group A Streptococcal infections in children and adolescents in Denmark during 2022–23 compared with 2016–17 to 2021–22: A nationwide, multicentre, population-based cohort study. Lancet Child Adolesc Health 8:112–121. https://doi.org/10.1016/S2352-4642(23)00295-X
  32. Nygaard U, Holm M, Rabie H et al. (2024b) The pattern of childhood infections during and after the COVID-19 pandemic. Lancet Child Adolesc Health 8:910–920. https://doi.org/10.1016/S2352-4642(24)00236-0
  33. Pellon A, Palacios A, Abecia L et al. (2025) Friends to remember: Innate immune memory regulation by the microbiota. Trends Microbiol 33:510–520. https://doi.org/10.1016/j.tim.2024.12.002
  34. Randolph HE, Barreiro LB (2020) Herd immunity: Understanding COVID-19. Immunity 52:737–741. https://doi.org/10.1016/j.immuni.2020.04.012
  35. Rodriguez-Ruiz JP, Lin Q, Lammens C et al. (2023) Increase in bloodstream infections caused by emm1 group A Streptococcus correlates with emergence of toxigenic M1(UK), Belgium, May 2022 to August 2023. Euro Surveill 28:2300422. https://doi.org/10.2807/1560-7917.Es.2023.28.36.2300422
  36. Stražar M, Mourits VP, Koeken VACM et al. (2021) The influence of the gut microbiome on BCG-induced trained immunity. Genome Biol 22:275. https://doi.org/10.1186/s13059-021-02482-0
  37. Su MS-W, Cheng Y-L, Lin Y-S et al. (2024) Interplay between group A Streptococcus and host innate immune responses. Microbiol Mol Biol Rev 88:e0005222. https://doi.org/10.1128/mmbr.00052-22
  38. Tomidis Chatzimanouil MK, Rößler S, Nurjadi D et al. (2025) Post-COVID-19-pandemic changes and clinical characteristics of invasive group A Streptococcal infections from 2015 to 2023. Infection 53:991–1000. https://doi.org/10.1007/s15010-024-02413-8
  39. Tran BT, Jeyanathan V, Cao R et al. (2025) Hematopoietic stem and progenitor cells as a reservoir for trained immunity. Elife 14:e106610. https://doi.org/10.7554/eLife.106610
  40. Tse H, Bao JY, Davies MR et al. (2012) Molecular characterization of the 2011 Hong Kong scarlet fever outbreak. J Infect Dis 206:341–351. https://doi.org/10.1093/infdis/jis362
  41. UK Health Security Agency. (2026) https://www.gov.uk/government/organisations/uk-health-security-agency. Accessed 30 March 2026
  42. Vieira A, Wan Y, Ryan Y et al. (2024) Rapid expansion and international spread of M1UK in the post-pandemic UK upsurge of Streptococcus pyogenes. Nat Commun 15:3916. https://doi.org/10.1038/s41467-024-47929-7
  43. Vuscan P, Kischkel B, Joosten LAB et al. (2024) Trained immunity: General and emerging concepts. Immunol Rev 323:164–185. https://doi.org/10.1111/imr.13326
  44. Walker MJ, Barnett TC, McArthur JD et al. (2014) Disease manifestations and pathogenic mechanisms of Group A Streptococcus. Clin Microbiol Rev 27:264–301. https://doi.org/10.1128/cmr.00101-13
  45. Yang B, Wu J, Hou X et al. (2025) Memory in misfire: The gut microbiome-trained immunity circuit in inflammatory bowel diseases. Int J Mol Sci 26:9663. https://doi.org/10.3390/ijms26199663
Language: English
Submitted on: Apr 10, 2026
Accepted on: Apr 23, 2026
Published on: Jun 22, 2026
In partnership with: Paradigm Publishing Services
Publication frequency: 1 issue per year

© 2026 Janusz Marcinkiewicz, published by Hirszfeld Institute of Immunology and Experimental Therapy
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.